Hey @Zissou , thanks. What do you think about the FY23 and their potential to get back to previous profitability.
Statutory revenue: $69.8 million, up 11% on pcp , assisted by the TCV growth, but offset by lower services revenue.
Statutory EBITDA was up 42% to $12.1 million.
Net Profit After Tax and before non-cash impairment (NPAT) of $2.6 million
= EBITDA of 17.3% and NPAT of 3.7%
Whereas before in 2019, EBITDA was 40%
Hey @Zissou , thanks. What do you think about the FY23 and their...
Add IRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
-0.025(4.00%) |
Mkt cap ! $104.7M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 63.0¢ | 60.0¢ | $605.3K | 988.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27000 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 5927 | 3 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| IRI (ASX) Chart |